The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection DOI Creative Commons
Amirhosein Faghihkhorasani,

Hanan Hassan Ahmed,

Noor Muhammad Mashool

и другие.

Virology Journal, Год журнала: 2023, Номер 20(1)

Опубликована: Окт. 3, 2023

Abstract Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria bacteria-derived products. They accumulate diseased tissues despite physical obstacles, where they can launch antiviral immunity. The ability genetically chemically modify them means that vaccinations manufactured delivered affected more safely effectively. objective this study is provide an overview latest advancements field utilizing bacterial derivatives as carriers administering medication treat diseases such SARS-CoV-2, hepatitis B virus, C immunodeficiency papillomavirus, influenza, Ebola virus. Graphical

Язык: Английский

Bacterial Membrane Vesicles as Smart Drug Delivery and Carrier Systems: A New Nanosystems Tool for Current Anticancer and Antimicrobial Therapy DOI Creative Commons
Pınar Aytar Çelik, Kubra Erdogan-Gover, Dilan Barut

и другие.

Pharmaceutics, Год журнала: 2023, Номер 15(4), С. 1052 - 1052

Опубликована: Март 24, 2023

Bacterial membrane vesicles (BMVs) are known to be critical communication tools in several pathophysiological processes between bacteria and host cells. Given this situation, BMVs for transporting delivering exogenous therapeutic cargoes have been inspiring as promising platforms developing smart drug delivery systems (SDDSs). In the first section of review paper, starting with an introduction pharmaceutical technology nanotechnology, we delve into design classification SDDSs. We discuss characteristics including their size, shape, charge, effective production purification techniques, different methods used cargo loading encapsulation. also shed light on release mechanism, carriers, recent remarkable findings potential anticancer antimicrobial therapy. Furthermore, covers safety challenges that need overcome clinical use. Finally, advancements prospects SDDSs highlight revolutionizing fields nanomedicine delivery. conclusion, paper aims provide a comprehensive overview state-of-the-art field SDDSs, encompassing design, composition, fabrication, purification, characterization, well various strategies targeted Considering information, aim is researchers understanding current state enabling them identify gaps formulate new hypotheses accelerate progress field.

Язык: Английский

Процитировано

22

Intestinal organoids and organoids extracellular vesicles for inflammatory bowel disease treatment DOI Creative Commons
Han Liu,

Jinru Sun,

Mingkai Wang

и другие.

Chemical Engineering Journal, Год журнала: 2023, Номер 465, С. 142842 - 142842

Опубликована: Апрель 10, 2023

Язык: Английский

Процитировано

22

Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy DOI Creative Commons
Dongdong Wang, Jiawei Liu, Changlai Wang

и другие.

Nature Communications, Год журнала: 2023, Номер 14(1)

Опубликована: Май 23, 2023

Abstract Cancer immunotherapy is revolutionizing oncology. The marriage of nanotechnology and offers a great opportunity to amplify antitumor immune response in safe effective manner. Here, electrochemically active Shewanella oneidensis MR-1 can be applied produce FDA-approved Prussian blue nanoparticles on large-scale. We present mitochondria-targeting nanoplatform, MiBaMc, which consists decorated bacteria membrane fragments having further modifications with chlorin e6 triphenylphosphine. find that MiBaMc specifically targets mitochondria induces amplified photo-damages immunogenic cell death tumor cells under light irradiation. released antigens subsequently promote the maturation dendritic tumor-draining lymph nodes, eliciting T cell-mediated response. In two tumor-bearing mouse models using female mice, triggered phototherapy synergizes anti-PDL1 blocking antibody for enhanced inhibition. Collectively, study demonstrates biological precipitation synthetic strategy targeted holds potential preparation microbial membrane-based nanoplatforms boost immunity.

Язык: Английский

Процитировано

22

Metal-polyphenol “prison” attenuated bacterial outer membrane vesicle for chemodynamics promoted in situ tumor vaccines DOI
Weidong Nie,

Anqi Jiang,

Ou Xu

и другие.

Biomaterials, Год журнала: 2023, Номер 304, С. 122396 - 122396

Опубликована: Ноя. 23, 2023

Язык: Английский

Процитировано

22

The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection DOI Creative Commons
Amirhosein Faghihkhorasani,

Hanan Hassan Ahmed,

Noor Muhammad Mashool

и другие.

Virology Journal, Год журнала: 2023, Номер 20(1)

Опубликована: Окт. 3, 2023

Abstract Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria bacteria-derived products. They accumulate diseased tissues despite physical obstacles, where they can launch antiviral immunity. The ability genetically chemically modify them means that vaccinations manufactured delivered affected more safely effectively. objective this study is provide an overview latest advancements field utilizing bacterial derivatives as carriers administering medication treat diseases such SARS-CoV-2, hepatitis B virus, C immunodeficiency papillomavirus, influenza, Ebola virus. Graphical

Язык: Английский

Процитировано

20